Aich Tapas Kumar, Gupta Uttam, Subedi Sandip
Department of Psychiatry, Baba Raghav Das Medical College, Gorakhpur, Uttar Pradesh, India.
Department of Psychiatry, Universal College of Medical Sciences, Bhairahawa, Nepal.
Indian J Psychiatry. 2018 Jan-Mar;60(1):78-83. doi: 10.4103/psychiatry.IndianJPsychiatry_349_17.
Chronic daily headache (CDH) patients respond better with a combination of anti-migraine and anti-stress medications, irrespective of clinical diagnosis of chronic migraine (CM) or chronic tension-type headache (CTTH).
"CDH: Mix headache" type is a valid clinical entity.
A total of 70 participants fulfilling the diagnosis of "primary CDH", aged between 15 and 55 years were taken up for the present study. All these patients were subdivided into either CM or CTTH, based on the predominance of symptom profiles in these patients, in confirmation with the International Headache Society guidelines (International Classification of Headache Disorders-2, 2004). Schedules for clinical assessment in neuropsychiatry (SCAN) were applied to these patients to collect information about any mental or behavioral symptoms present at the time of the study. Psychiatric comorbidity was confirmed according to the International Classification of Diseases (ICD)-10.
Forty-eight (68.6%) patients could be differentiated into CM and rest 22 (31.4%) patients were given a diagnosis of CTTH. SCAN and ICD-10 diagnosis revealed the presence of comorbid anxiety and depressive illness in 47 (67.2%) patients. Thirty-four of them belonged to CM (MH) group and the rest 13 had CTTH.
We propose that these 47 (67.2%) patients of CDH form our special category of "CDH - mix headache" subtype. Thus, 14 (20%) patients constitute "CDH - migraine" subtype and rest 9 (12.8%) patients have a diagnosis of "CDH - tension headache" subtype.
Findings of the present study validate the concept of "mix headache" and explains the clinical observation that chronic daily headache (CDH) patients responds better with a combination of anti-migraine and anti-stress medications.
慢性每日头痛(CDH)患者使用抗偏头痛药物和抗应激药物联合治疗的效果更佳,无论其临床诊断为慢性偏头痛(CM)还是慢性紧张型头痛(CTTH)。
“CDH:混合型头痛”类型是一种有效的临床实体。
本研究共纳入70名符合“原发性CDH”诊断标准、年龄在15至55岁之间的参与者。根据这些患者症状特征的优势情况,并参照国际头痛协会指南(《国际头痛疾病分类第二版》,2004年),将所有这些患者分为CM或CTTH。对这些患者应用神经精神病学临床评估量表(SCAN)来收集研究时存在的任何精神或行为症状的信息。根据《国际疾病分类》(ICD)-10确诊精神疾病共病情况。
48名(68.6%)患者可被鉴别为CM,其余22名(31.4%)患者被诊断为CTTH。SCAN和ICD-10诊断显示,47名(67.2%)患者存在焦虑和抑郁共病。其中34名属于CM(偏头痛)组,其余13名患有CTTH。
我们提出,这47名(67.2%)CDH患者构成了我们特殊的“CDH - 混合型头痛”亚型类别。因此,14名(20%)患者构成“CDH - 偏头痛”亚型,其余9名(12.8%)患者被诊断为“CDH - 紧张型头痛”亚型。
本研究结果验证了“混合型头痛”的概念,并解释了慢性每日头痛(CDH)患者使用抗偏头痛药物和抗应激药物联合治疗效果更佳这一临床观察结果。